Analyst Reco. DexCom, Inc.

Equities

DXCM

US2521311074

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
137.9 ^USD	+2.89%		+3.00%	+11.10%

Apr. 22	John Chevedden Submits a Shareholder Proposal to DexCom	CI
Apr. 22	Myra K. Young Submits a Shareholder Proposal to DexCom	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dexcom Insider Sold Shares Worth $274,242, According to a Recent SEC Filing	Apr. 16	MT
BTIG Adjusts DexCom's Price Target to $156 From $150	Apr. 15	MT
UBS Raises DexCom's Price Target to $163 From $153, Maintains Buy Rating	Apr. 10	MT
Citigroup Raises Price Target on DexCom to $161 From $148, Keeps Buy Rating	Apr. 03	MT
DexCom Initiated at Outperform by RBC, Price Target Set at $165 on View for Revenue Upside Amid Rapidly Expanding Market	Mar. 12	MT
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	Feb. 21
UBS Adjusts DexCom Price Target to $153 From $149, Maintains Buy Rating	Feb. 09	MT
This time it's for real	Feb. 09
Bernstein Adjusts DexCom Price Target to $150 From $135, Maintains Outperform Rating	Feb. 09	MT
Leerink Partners Adjusts DexCom Price Target to $142 From $144, Maintains Outperform Rating	Feb. 09	MT
TD Cowen Adjusts DexCom Price Target to $160 From $110, Maintains Outperform Rating	Feb. 09	MT
Canaccord Genuity Adjusts DexCom Price Target to $144 From $137, Maintains Buy Rating	Feb. 09	MT
ANALYST RECOMMENDATIONS : Lululemon, Nvidia, PayPal, Spotify, Uber...	Feb. 09
Raymond James Raises DexCom Price Target to $151 From $147, Maintains Strong Buy Rating	Jan. 23	MT
UBS Adjusts DexCom Price Target to $149 From $145, Maintains Buy Rating	Jan. 22	MT
Raymond James Raises Price Target on DexCom to $147 From $131, Maintains Strong Buy Rating	Jan. 03	MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	Jan. 03
ANALYST RECOMMENDATIONS : Amgen, Eli Lilly, Micron Salesforce, Texas Instruments...	Dec. 21
Piper Sandler Adjusts DexCom Price Target to $150 From $135, Maintains Overweight Rating	Dec. 19	MT
Wells Fargo Increases Price Target on DexCom to $136 From $110, Maintains Overweight Rating	Dec. 13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

DexCom is still in the running

March 07, 2024 at 04:49 am EST